GD2 peptide mimics
US6939948B1 · kind B1 · utility
0Cited by
2References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 24, 2003 |
| Grant date | Sep 6, 2005 |
| Priority date | — |
| Expiry date | Mar 28, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides peptide mimics for GD2 ganglioside. The peptide mimics were identified by panning phage display peptide libraries with an anti-GD2 monoclonal antibody. The identified peptide mimics can be used as immunogens for cancer therapy such as for melanoma and neuroblastoma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.